留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

多肽类化合物在颅脑创伤中的研究进展

马凯源,  章越凡,  李铁军

downloadPDF
文章导航 > 药学实践与服务  > 2017 >  35(6): 495-498,529
马凯源, 章越凡, 李铁军. 多肽类化合物在颅脑创伤中的研究进展[J]. 药学实践与服务, 2017, 35(6): 495-498,529. doi: 10.3969/j.issn.1006-0111.2017.06.004
引用本文: 马凯源, 章越凡, 李铁军. 多肽类化合物在颅脑创伤中的研究进展[J]. 药学实践与服务, 2017, 35(6): 495-498,529. doi: 10.3969/j.issn.1006-0111.2017.06.004
shu
MA Kaiyuan, ZHANG Yuefan, LI Tiejun. Research progress of peptide compounds in traumatic brain injury[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(6): 495-498,529. doi: 10.3969/j.issn.1006-0111.2017.06.004
Citation: MA Kaiyuan, ZHANG Yuefan, LI Tiejun. Research progress of peptide compounds in traumatic brain injury[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(6): 495-498,529. doi: 10.3969/j.issn.1006-0111.2017.06.004
shu

多肽类化合物在颅脑创伤中的研究进展

doi: 10.3969/j.issn.1006-0111.2017.06.004
  • 1.

    安徽中医药大学药学院, 安徽 合肥 230012

  • 2.

    第二军医大学药学院药理学教研室, 上海 200433

  • 3.

    安徽中医药大学药学院, 安徽 合肥 230012;第二军医大学药学院药理学教研室, 上海 200433

基金项目: 上海市卫生和计划生育委员会科研课题（201640404）

Research progress of peptide compounds in traumatic brain injury

  • 1.

    School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China

  • 2.

    Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

  • 3.

    School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China;Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

  • 摘要: 颅脑创伤每年在全球造成严重的伤亡，至今研究者们依然没有找到有效的临床治疗药物。肽类物质以其安全、易耐受等优势逐渐成为研究开发的热点。对多肽类化合物在颅脑创伤中的神经保护和抗炎作用进行综述。
    Abstract: Traumatic brain injuries(TBI) have caused severe injuries and deaths all over the world, but so far researchers have not found an effective drug in treating TBI on clinic. However, peptides have gradually been in a hot research with its advantages which include safety and tolerance etc. The neuroprotective and anti-inflammatory effects of several peptide compounds in traumatic brain injury are reviewed in this paper.
  • [1] 惠纪元,龚如,梁玉敏,等. 中国颅脑创伤数据库:短期预后因素分析[J]. 中华神经外科杂志,2014,30(1):56-58.
    [2] 江基尧. 中国颅脑创伤研究的现状与未来[J]. 中华医学杂志,2013,93(23):1761-1762.
    [3] Stein DG,Wright DW. Progesterone in the clinical treatment of acute traumatic brain injury[J]. Expert Opin Investig Drugs,2010,19(7):847-857.
    [4] 王克全,徐寒梅. 多肽类药物的研究进展[J]. 药学进展,2015,39(9):642-650.
    [5] Lee EH,Seo SR. Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases[J]. BMB Rep,2014,47(7):369-375.
    [6] Katahira M,Yone K,Arishima Y,et al.The neuroprotective effects of PACAP on spinal cord injury (SCI) in rats[J]. Regul Pept,2003,115(1):49.
    [7] Reglodi D,Kiss P,Lubics A,et al. Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo[J]. Curr Pharm Des,2011,17(10):962-972.
    [8] Farkas O,Tamás A,Zsombok A,et al. Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury[J]. Regul Pept,2004,123(1-3):69-75.
    [9] Vukojevic J,Vrdoljak B,Malekinusic D,et al. The effect of BPC 157 on ischemic/reperfusion injuriesin rat brain[J]. FASEB J,2016,30(1Suppl):705-706.
    [10] Tudor M,Jandric I,Marovic A,et al. Traumatic brain injury in mice and pentadecapeptide BPC 157 effect[J]. Regul Pept,2010,160(1-3):26-32.
    [11] Tohyama Y,Sikirié P,Diksic M. Effects of pentadecapeptide BPC157 on regional serotonin synthesis in the rat brain:alpha-methyl-L-tryptophan autoradiographic measurements[J]. Life Sci,2004,76(3):345-357.
    [12] Amiri-Nikpour MR,Nazarbaqhi S,Ahmadi-Salmasi B,et al. Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke[J]. Neuropsychiatr Dis Treat,2014,10:2299.
    [13] Sharma HS,Zimmermann-Meinzingen S,Johanson CE. Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change,brain pathology,and functional deficits following traumatic brain injury in the rat[J]. Ann N Y Acad Sci,2010,1199:125-137.
    [14] Chen CC,Wei ST,Tsaia SC,et al. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients:double-blind,placebo-controlled,randomized study[J]. Br J Neurosurg,2013,27(6):803-807.
    [15] álvarez XA,Figueroa J,Muresanu D. Peptidergic drugs for the treatment of traumatic brain injury[J]. Futr Neurol,2013,8(2):175-192.
    [16] Faden AI,Fox GB,Fan L,et al. Novel TRH analog improves motor and cognitive recovery after traumatic brain injury in rodents[J]. Am J Physiol,1999,277(4 Pt 2):R1196-R1204.
    [17] Jain KK. Neuroprotection in traumatic brain injury[J]. Drug Discov Today, 2008,13(23-24):1082-1089.
    [18] Faden AI,Knoblach SM,Cernak I,et al. Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo[J].J Cerebr Blood Flow Metabol,2003:342-354.
    [19] Faden AI,Movsesyan VA,Knoblach SM,et al. Neuroprotective effects of novel small peptides in vitro and after brain injury[J]. Neuropharmacology,2005,49(3):410-424.
    [20] Faden AI,Knoblach SM,Movsesyan VA,et al. Novel small peptides with neuroprotective and nootropic properties[J]. J Alzheimers Dis,2004,6(6 Suppl):S93-S97.
    [21] 李淑敏. 促红细胞生成素的临床应用进展[J]. 职业与健康,2013,29(21):2862-2864.
    [22] Corwin HL,Gettinger A,Fabian TC,et al. Efficacy and safety of epoetin Alfa in criticallyⅢ patients[J]. New Engl J Med,2007,357(10):965-976.
    [23] Collino M,Thiemermann C,Cerami A,et al. Flipping the molecular switch for innate protection and repair of tissues:Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin[J]. Pharmacol Ther,2015,151:32-40.
    [24] Robertson CS,Cherian L,Shah M,et al. Neuroprotection with an erythropoietin mimetic peptide (pHBSP) in a model of mild traumatic brain injury complicated by hemorrhagic shock[J]. J Neurotr,2012,29(6):1156-1166.
    [25] Verghese PB,Castellano JM,Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders[J]. Lancet Neurol,2011,10(3):241-252.
    [26] Jiang Y,Brody DL. Administration of COG1410 reduces axonal amyloid precursor protein immunoreactivity and microglial activation after controlled cortical impact in mice[J]. J Neurotr,2012,29(13):2332-2341.
    [27] Laskowitz DT,Mckenna SE,Song P,et al. COG1410,a novel apolipoprotein E-basedpeptide,improves functional recovery in a murine model of traumatic brain injury[J]. J Neurotr,2007,24(7):1093-1107.
    [28] 贺杰,庞金伟,吴越,等. 载脂蛋白E短肽COG1410对蛛网膜下腔出血后早期脑水肿的影响[J]. 第三军医大学学报,2016,38(4):350-355.
    [29] Wu Y,Pang J,Peng J,et al. An apoE-derived mimic peptide,COG1410,alleviates early brain injury via reducing apoptosis and neuroinflammation in a mouse model of subarachnoid hemorrhage[J].Neurosci Lett,2016,627:92-99.
  • [1] 宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅.  帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
    [2] 张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英.  二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
    [3] 夏哲炜, 曾垣烨, 朱海菲, 李育, 陈啸飞.  核磁共振磷谱法测定磷酸氢钙咀嚼片中药物含量 . 药学实践与服务, 2024, 42(9): 399-401, 406. doi: 10.12206/j.issn.2097-2024.202404063
    [4] 孙丹倪, 黄勇, 张嘉宝, 王培.  代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
    [5] 陈怡君, 王卓, 何苗, 张宇, 田泾.  泌尿系统碎石术抗菌药物预防使用合理管控实践 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402034
    [6] 张岩, 李炎君, 刘家荟, 邓娇, 原苑, 张敬一.  药物性肝损伤不良反应分析 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404034
    [7] 张元林, 宋凯, 孙蕊, 舒飞, 舒丽芯, 杨樟卫.  基于真实世界数据的药物利用研究综述 . 药学实践与服务, 2024, 42(6): 238-243. doi: 10.12206/j.issn.2097-2024.202312010
    [8] 张莲卿, 骆岩, 杨提, 姚佳晨, 李文艳.  基于FAERS数据库的艾塞那肽微球不良事件信号挖掘与研究 . 药学实践与服务, 2024, 42(10): 445-450. doi: 10.12206/j.issn.2097-2024.202403057
    [9] 张广雨, 杜晶, 刘梦珍, 朱丹妮, 闫慧, 刘冲.  新斯的明与山莨菪碱联合应用对肺型氧中毒的保护作用及其机制的研究 . 药学实践与服务, 2024, 42(10): 433-438, 444. doi: 10.12206/j.issn.2097-2024.202310049
    [10] 迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛.  负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
    [11] 郭灵怡, 刘艳超, 高路, 刘瑞瑶, 吕权真, 俞媛.  醋酸卡泊芬净单硬脂酸甘油酯纳米粒抗白色念珠菌感染的增效作用研究 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202310043
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  2456
  • HTML全文浏览量:  340
  • PDF下载量:  490
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-07-17
  • 修回日期:  2017-10-17

多肽类化合物在颅脑创伤中的研究进展

doi: 10.3969/j.issn.1006-0111.2017.06.004
  • 1. 安徽中医药大学药学院, 安徽 合肥 230012
  • 2. 第二军医大学药学院药理学教研室, 上海 200433
  • 3. 安徽中医药大学药学院, 安徽 合肥 230012;第二军医大学药学院药理学教研室, 上海 200433
    • 基金项目:  上海市卫生和计划生育委员会科研课题（201640404）
  • 收稿日期: 2017-07-17
  • 修回日期: 2017-10-17

摘要: 颅脑创伤每年在全球造成严重的伤亡，至今研究者们依然没有找到有效的临床治疗药物。肽类物质以其安全、易耐受等优势逐渐成为研究开发的热点。对多肽类化合物在颅脑创伤中的神经保护和抗炎作用进行综述。

English Abstract

马凯源, 章越凡, 李铁军. 多肽类化合物在颅脑创伤中的研究进展[J]. 药学实践与服务, 2017, 35(6): 495-498,529. doi: 10.3969/j.issn.1006-0111.2017.06.004
引用本文: 马凯源, 章越凡, 李铁军. 多肽类化合物在颅脑创伤中的研究进展[J]. 药学实践与服务, 2017, 35(6): 495-498,529. doi: 10.3969/j.issn.1006-0111.2017.06.004
shu
MA Kaiyuan, ZHANG Yuefan, LI Tiejun. Research progress of peptide compounds in traumatic brain injury[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(6): 495-498,529. doi: 10.3969/j.issn.1006-0111.2017.06.004
Citation: MA Kaiyuan, ZHANG Yuefan, LI Tiejun. Research progress of peptide compounds in traumatic brain injury[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(6): 495-498,529. doi: 10.3969/j.issn.1006-0111.2017.06.004
shu

    全文HTML

参考文献 (29)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: [email protected]

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计